VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness-Reference-Cited by-同舟云学术

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

Published:2019 Issue:3 Volume:9 Page:661-675
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

Ndiaye Papa Diogop,Dufies Maeva,Giuliano Sandy,Douguet Laetitia,Grépin Renaud,Durivault Jérôme,Lenormand Philippe,Glisse Natacha,Mintcheva Janita,Vouret-Craviari Valérie,Mograbi Baharia,Wurmser Maud,Ambrosetti Damien,Rioux-Leclercq Nathalie,Maire Pascal,Pagès Gilles

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated physiological, whole transcriptomic and functional analysis reveals the regulatory mechanism in the liver of rainbow trout (Oncorhynchus mykiss) in response to short-term and chronic hypoxia stress;Aquaculture;2024-12

2. Comparative effects of proton and photon irradiation on the molecular and cellular profiles of triple-negative breast cancer: the crucial impact of VEGFC on tumor microenvironment remodeling;2024-08-19

3. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance;International Immunopharmacology;2024-07

4. Extremely low-frequency electromagnetic field (ELF-EMF) induced alterations in gene expression and cytokine secretion in clear cell renal carcinoma cells;Medycyna Pracy;2024-05-08

5. A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR⁺CXCL-CXCR1/2 Pathway Inhibitor;ACS Medicinal Chemistry Letters;2024-04-03